Top Markets
#1 pippin pippin +16.86%
#2 Aria.AI Aria.AI +14.74%
#3 River Pts River Pts +14.68%
#4 Janction Janction +13.50%
#5 Strategic Oil Supply Strategic Oil Supply +12.21%
#6 TRIA TRIA +12.05%
#7 DeXe DeXe +11.31%
#8 Osaka Protocol Osaka Protocol +10.09%
#9 Lava Network Lava Network +8.51%
#10 Orochi Network Orochi Network +8.44%
Coin of the day
pippin pippin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$37.45
Marktkapitalisatie
$166.43B
Verandering (1 dag)
-2.55%
Verandering (1 jaar)
-53.09%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Healthcare
Winst voor Novo Nordisk A/S (NVO)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Novo Nordisk A/S bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Novo Nordisk A/S van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.45B -
NL